Hims & Hers Offers Access to GLP-1s Starting At $199 A Month
Hims & Hers is now providing access to compounded GLP-1s. Patients also receive unlimited medical consultations with a licensed provider.
Hims & Hers CMO: The Healthcare Industry’s Strengths and Weaknesses Regarding Telehealth
Telehealth is great at expanding access to care, but sometimes the quality isn't there, according to Dr. Pat Carroll, chief medical officer of Hims & Hers.
presented by
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Hims & Hers Gets Into Weight Loss Treatment
Hims & Hers unveiled a new weight loss program on Monday that includes access to medications, educational content and digital tracking tools.
Hims & Hers Dips Into Men’s Cardiovascular Health
Hims & Hers can now provide treatment to men for cardiovascular issues, the company recently announced. This treatment combines sexual health and heart health together in a single pill.
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
McKesson Ventures highlights investment priorities amidst a trail of successful exits
McKesson Ventures is one of the most active investors in the biopharma software sector with Komodo Health, Evidation and M2Gen among its portfolio companies.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.